Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden · Delayed Price · Currency is SEK 9.98
+0.03 (0.30%)
Oct 13, 2026, 12:38 PM CET
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 4.64 billion as of October 12, 2026. It is the 15,358th most valuable company in the world and the 191st biggest in Sweden. Its market cap has increased by 114.28% in one year.
Market Cap
4.64B
Enterprise Value
4.33B
Revenue
66.00M
Global Rank
Country Rank
#191 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 4.64B, an increase of 1,963.30%. That is a compound annual growth rate of 21.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 4.64B | 119.90% |
| Dec 30, 2025 | 2.11B | -16.09% |
| Dec 30, 2024 | 2.51B | 54.03% |
| Dec 29, 2023 | 1.63B | 7.15% |
| Dec 30, 2022 | 1.52B | 37.56% |
| Dec 30, 2021 | 1.11B | -10.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.66B |
| Vicore Pharma Holding AB | 2.53B |
| BioInvent International AB | 1.53B |
| Genovis AB (publ.) | 1.37B |
| Saniona AB | 1.32B |
| Flerie AB | 1.32B |
| Oncopeptides AB | 1.17B |
| Infant Bacterial Therapeutics AB | 975.33M |